Page last updated: 2024-08-21

thiazolidines and Albuminuria

thiazolidines has been researched along with Albuminuria in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aa, JY; Ding, F; Gao, HX; He, J; Sun, RB; Wang, GJ; Wang, JK; Xie, Y; Yang, N; Zeng, CH; Zhang, JW; Zhu, XD1
Aoki, K; Ashiya, Y; Kamiko, K; Kamiyama, H; Minagawa, F; Nakajima, S; Shibata, E; Shinoda, K; Taguri, M; Terauchi, Y1
Aoki, C; Aso, Y; Inoue, T; Sagara, M; Suzuki, K; Taguchi, I; Tanaka, S1
Ebata, K; Haneda, M; Itagaki, I; Kamanaka, Y; Kikkawa, R; Shigeta, Y; Shimizu, K1
Inokuchi, T; Isogai, S; Ohe, K1

Trials

2 trial(s) available for thiazolidines and Albuminuria

ArticleYear
Comparison of the administration of teneligliptin every day versus every other day in Japanese patients with type 2 diabetes: a randomized non-inferior test.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:2

    Topics: Aged; Albuminuria; Asian People; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Lipid Metabolism; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Pyrazoles; Thiazolidines; Treatment Outcome

2015
Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study.
    Cardiovascular diabetology, 2016, May-17, Volume: 15

    Topics: Aged; Aged, 80 and over; Albuminuria; Case-Control Studies; Diabetes Mellitus, Type 2; Endothelium; Female; Humans; Male; Middle Aged; Oxidative Stress; Pyrazoles; Renal Insufficiency, Chronic; Thiazolidines; Treatment Outcome

2016

Other Studies

3 other study(ies) available for thiazolidines and Albuminuria

ArticleYear
The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
    Acta pharmacologica Sinica, 2019, Volume: 40, Issue:1

    Topics: Albuminuria; Aldehyde Reductase; Animals; Diabetic Nephropathies; Enzyme Inhibitors; Fructose; Inositol; Kidney; Male; Metabolomics; Mice; Protective Agents; Rhodanine; Sorbitol; Thiazolidines

2019
The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats.
    Diabetes research and clinical practice, 1994, Volume: 25, Issue:3

    Topics: Albuminuria; Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glomerular Filtration Rate; Glomerular Mesangium; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Renal Circulation; Rhodanine; Thiazolidines

1994
Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
    Diabetes research and clinical practice, 1995, Volume: 30, Issue:2

    Topics: Administration, Oral; Albuminuria; Aldehyde Reductase; Animals; Anions; Basement Membrane; Blood Glucose; Blood Pressure; Cohort Studies; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Erythrocytes; Kidney Glomerulus; Male; Rats; Rats, Wistar; Rhodanine; Sorbitol; Thiazolidines; Time Factors

1995